Payden & Rygel’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-56,300
Closed -$1.67M 133
2021
Q3
$1.67M Sell
56,300
-604,400
-91% -$17.6M 0.09% 82
2021
Q2
$17.6M Sell
660,700
-31,700
-5% -$897K 0.84% 71
2021
Q1
$19.1M Buy
+692,400
New +$19.4M 0.89% 62
2020
Q3
Sell
-988,400
Closed -$26.2M 127
2020
Q2
$26.2M Hold
988,400
1.67% 25
2020
Q1
$24M Buy
988,400
+44,900
+5% +$1.36M 1.73% 26
2019
Q4
$28.6M Buy
943,500
+137,900
+17% +$4.12M 1.79% 27
2019
Q3
$23.7M Buy
+805,600
New +$22.5M 1.61% 32

Other funds holding HR

Payden & Rygel's HR Position: Q4 2021 in Review

Payden & Rygel sold out of Healthcare Realty (HR) in Q4 2021, closing a stake of 56,300 shares — an estimated $1.67M sold.

Payden & Rygel first reported a position in HR in Q3 2019 and held it in 7 quarters. The position peaked at $28.6M in Q4 2019. 387 funds tracked by Wall St. Rank hold HR as of Q4 2021.

  • Payden & Rygel reported no remaining Healthcare Realty position as of Q4 2021 after selling out during the quarter.
  • Payden & Rygel sold 56,300 Healthcare Realty shares in Q4 2021, an estimated $1.67M.
  • Payden & Rygel first reported a position in Healthcare Realty in Q3 2019 and held it in 7 quarters.
  • Payden & Rygel's Healthcare Realty position peaked at $28.6M in Q4 2019.
  • 387 funds tracked by Wall St. Rank held Healthcare Realty as of Q4 2021.

Based on Payden & Rygel's 13F filing for Q4 2021, filed 11 Feb 2022.